Geist will focus on growing the firm’s digital biomarker measurement technology Simoa, including its neurology franchise, as well as COVID-19, infectious disease, immunology and oncology products.

Steris’ chief said that Key Surgical’s “focus on the sterile processing department, operating room and endoscopy fits perfectly with our core healthcare customers.”